1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Fujitsu Limited
  6. News
  7. Summary
    6702   JP3818000006


Delayed Japan Exchange  -  09:45 2022-08-15 pm EDT
16950.00 JPY   -0.29%
08/10Nikkei 225 Down 0.6% on Tech Slump
08/02UBS Adjusts Fujitsu's Price Target to 25,000 Yen to 27,600 Yen, Keeps at Buy
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fujitsu and Salesforce Japan start collaboration on healthcare solutions for the Japan market

06/20/2022 | 11:08pm EDT

TOKYO, Jun 21, 2022 - (JCN Newswire) - - Fujitsu and Salesforce Japan Co., Ltd. (hereinafter Salesforce Japan) today announced the start of a collaboration to create new digital solutions for the healthcare sector in the Japan market.

The two companies will promote this initiative by leveraging Fujitsu's expertise in the trusted handling of medical and pharmaceutical data and computing technologies and Salesforce Japan's track record and expertise as an industry leader in customer relationship management (CRM).

As the first step of their collaboration, Fujitsu and Salesforce Japan will work together to develop digital solutions for insurance companies in Japan. The two companies will cooperate with insurance companies and medical institutions to support the development of insurance products that optimize the risk assessment of diseases by individuals based on data such as the possibility of diseases predicted by AI from medical and health data. The two parties aim for commercialization of the new solutions in Japan in fiscal 2023.

Through the new solutions, Fujitsu and Salesforce Japan will support the establishment of new product models for insurance companies and promote the broad use of personalized insurance products. The two companies thereby aim to contribute to the resolution of societal and economic issues including health concerns related to a variety of diseases associated with the extending life expectancy of individuals, the increase in treatment costs due to advanced medical care, and the cost of living in the retirement period.


As society confronts the challenges presented by declining birth rates, aging populations, new threats to public health, and changing lifestyles, insurance companies are working to provide personalized insurance products that are more closely tailored to each applicant?s unique needs.

To contribute to this effort, Fujitsu and Salesforce Japan, who started comprehensive cooperation on a global level in 2010, decided to further strengthen their relationship and expand their business through collaborative efforts to create solutions in the healthcare field.

Through the development of AI solutions that can predict individual disease risks, the two companies aim to support the development of optimized insurance products based on medical and health data provided by insurers and healthcare providers and to optimize business processes across the entire insurance business.

In this way, Fujitsu and Salesforce Japan will support insurance companies in offering prospective policyholders optimal insurance products and creating a new insurance model based on personal data that also covers prevention, diagnosis, treatment, and prognosis in a detailed and comprehensive manner.

Roles and responsibilities within the collaboration


- Development of a system in cooperation with medical institutions that enables the trusted use of medical data from electronic medical records based on the consent of patients

- Development of personalized healthcare services based on Fujitsu's own analysis to detect signs of a specific disease by utilizing "Fujitsu Computing as a Service (CaaS)," a service portfolio that makes it easy for users to take advantage of advanced computing and software technologies such as AI

Salesforce Japan:

- Comprehensive integration and analysis of a wide range of patient medical data to visualize the patient journey(1)

- Application of products to realize personalized medical experiences and patient-centered digital transformation (DX) (including ?Health Cloud,? a healthcare industry-specific CRM system that serves as the axis of patient-centric DX; ?MuleSoft,? to integrate external data and ?Tableau,? to analyze patient data)

Future plans

Fujitsu and Salesforce Japan will jointly develop digital solutions for insurance companies in Japan and aim for commercialization in fiscal 2023. Moving forward, the two companies will continue to pursue various initiatives to contribute to further innovations in the healthcare sector.

Fujitsu will work with insurance companies, medical institutions, pharmaceutical companies and medical device manufacturers to build a digital health ecosystem in which a wide range of data can be effectively linked and used with the latest digital technology in order to realize personalized healthcare throughout the entire life cycle. This initiative represents part of Fujitsu's ongoing efforts to contribute to the creation of a healthy society as part of its vision for "Healthy Living" under its global business brand Fujitsu Uvance to create a sustainable world.

Salesforce aims to realize "Connected Healthcare," which provides innovative and optimal healthcare to patients on an ongoing basis by connecting various healthcare stakeholders with patients through its ?Health Cloud."

Yoshinami Takahashi, (Corporate Executive Officer, EVP) Fujitsu Limited, comments:

"We are excited to start collaboration with Salesforce Japan in the healthcare field. By leveraging our respective strengths, I am confident that we can develop and provide innovative solutions to a wide range of challenges and tasks in this field.

The vision of "Healthy Living," one of the key focus areas under our global business brand Fujitsu Uvance is to create a world that enriches the life experience of everyone and continues to expand their potential. In order to realize this vision, it is essential to solve cross-cutting issues among consumers, insurance companies, medical institutions, pharmaceutical companies and other players. Fujitsu will create a digital health ecosystem to effectively link the data held by these players at the initiative of individuals to create new value and ultimately solve various issues.

Through this collaboration, we ultimately aim to deliver new solutions under our portfolio of "Healthy Living" offerings, contributing not only to the transformation of healthcare in Japan, but throughout the whole world."

Hidenori Tamura (Managing Executive Officer), Salesforce Japan Co., Ltd., Enterprise Finance & Region DX Sales Headquarters comments:

"There is a gap between the healthcare services demanded by consumers and the services actually provided. A Salesforce research shows that more than 80% of consumers are interested in personalized health services, while only about 30% of companies actually provide them. To meet the needs of consumers, it is essential for various players in the industry to connect and collaborate with patients to create solutions.

We have positioned our ?Health Cloud? as a solution where patients and healthcare players can connect and where healthcare players can create new solutions and values together.

Through our solutions centering on the ?Health Cloud,? we will promote patient-centered DX in Japan. As a major step towards achieving this goal, we will work with Fujitsu to provide innovative healthcare services and experiences that are optimal for each patient."

Amit Khanna SVP & GM, Health Care and LifeSciences, Salesforce, Inc. comments:

"Care is not just about one moment in time - care is longitudinal. In order to transition to more preventative, holistic care, the healthcare industry needs to embrace more connected, collaborative solutions and start integrating data from across different healthcare platforms to get a full picture of the patient. With this integrated end-to-end view, the healthcare industry can start working towards delivering personalized, tailored care to every patient."

(1) Patient journey :

The process of a patient's behavior and feelings during the period of treatment, such as seeking medical attention or taking medication, after the patient has developed a disease.

About Fujitsu

Fujitsu?s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.

About Salesforce

Salesforce is a global leader in customer relationship management (CRM), helping companies of all sizes and verticals digitally transform and reach their customers at 360 degrees. Learn more about Salesforce (NYSE: CRM) at www.salesforce.com.

Copyright 2022 JCN Newswire . All rights reserved.

© Japan Corporate News, source JCN Press Releases

Stocks mentioned in the article
ChangeLast1st jan.
FUJITSU LIMITED -0.32% 16950 Delayed Quote.-13.05%
SALESFORCE.COM, INC. 0.62% 191.06 Delayed Quote.-24.82%
All news about FUJITSU LIMITED
08/10Nikkei 225 Down 0.6% on Tech Slump
08/02UBS Adjusts Fujitsu's Price Target to 25,000 Yen to 27,600 Yen, Keeps at Buy
08/01Nikkei 225 Up 0.7% on Earnings, Wall Street Cues
08/01Japanese shares jump most in nearly two weeks on positive earnings
07/31Japanese shares edge higher with focus on earnings, global growth
07/31Fujitsu Shares Fall Sharply After Its Operating Profit Slipped 24% on Year
07/29FUJITSU : Notice of Disposal of Treasury Stock as Stock Compensation
07/29Fujitsu Limited Provides Consolidated Earnings Guidance for the Fiscal Year 2022
07/29FUJITSU LIMITED : 1st quarter results
More news
Analyst Recommendations on FUJITSU LIMITED
More recommendations
Sales 2023 3 746 B 28 149 M 28 149 M
Net income 2023 251 B 1 887 M 1 887 M
Net cash 2023 309 B 2 325 M 2 325 M
P/E ratio 2023 13,1x
Yield 2023 1,42%
Capitalization 3 341 B 25 104 M 25 104 M
EV / Sales 2023 0,81x
EV / Sales 2024 0,75x
Nbr of Employees 124 216
Free-Float 91,4%
Duration : Period :
Fujitsu Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FUJITSU LIMITED
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 17 000,00 JPY
Average target price 22 676,00 JPY
Spread / Average Target 33,4%
EPS Revisions
Managers and Directors
Takahito Tokita President, CEO & Representative Director
Takeshi Isobe Executive Officer, GM-Finance & Accounting
Yuzuru Fukuda Chief Information Officer
Vivek Mahajan Chief Technology Officer & Executive Officer
Hidenori Furuta COO, Representative Director & Vice President
Sector and Competitors
1st jan.Capi. (M$)
FUJITSU LIMITED-13.05%25 233
ACCENTURE PLC-22.73%202 694
INFOSYS LIMITED-15.56%83 978
SNOWFLAKE INC.-49.69%53 654